aura infection control limited
aura infection control limited Company Information
Company Number
08814266
Next Accounts
Dec 2025
Industry
Other human health activities
Directors
Shareholders
laura jayne wyndham edgar
edgar aic ltd
Group Structure
View All
Contact
Registered Address
hanover buildings, 11-13 hanover street, liverpool, merseyside, L1 3DN
Website
training.qwsonline.co.ukaura infection control limited Estimated Valuation
Pomanda estimates the enterprise value of AURA INFECTION CONTROL LIMITED at £2.4m based on a Turnover of £3.9m and 0.61x industry multiple (adjusted for size and gross margin).
aura infection control limited Estimated Valuation
Pomanda estimates the enterprise value of AURA INFECTION CONTROL LIMITED at £2.2m based on an EBITDA of £480.2k and a 4.67x industry multiple (adjusted for size and gross margin).
aura infection control limited Estimated Valuation
Pomanda estimates the enterprise value of AURA INFECTION CONTROL LIMITED at £1.7m based on Net Assets of £662.1k and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Aura Infection Control Limited Overview
Aura Infection Control Limited is a live company located in liverpool, L1 3DN with a Companies House number of 08814266. It operates in the other human health activities sector, SIC Code 86900. Founded in December 2013, it's largest shareholder is laura jayne wyndham edgar with a 50% stake. Aura Infection Control Limited is a established, small sized company, Pomanda has estimated its turnover at £3.9m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Aura Infection Control Limited Health Check
Pomanda's financial health check has awarded Aura Infection Control Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
4 Weak
Size
annual sales of £3.9m, make it larger than the average company (£730.5k)
- Aura Infection Control Limited
£730.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a faster rate (7.2%)
- Aura Infection Control Limited
7.2% - Industry AVG
Production
with a gross margin of 38.4%, this company has a comparable cost of product (38.4%)
- Aura Infection Control Limited
38.4% - Industry AVG
Profitability
an operating margin of 9.2% make it more profitable than the average company (5.2%)
- Aura Infection Control Limited
5.2% - Industry AVG
Employees
with 18 employees, this is similar to the industry average (19)
18 - Aura Infection Control Limited
19 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- Aura Infection Control Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £218k, this is more efficient (£45.5k)
- Aura Infection Control Limited
£45.5k - Industry AVG
Debtor Days
it gets paid by customers after 56 days, this is later than average (20 days)
- Aura Infection Control Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 24 days, this is slower than average (18 days)
- Aura Infection Control Limited
18 days - Industry AVG
Stock Days
it holds stock equivalent to 19 days, this is more than average (13 days)
- Aura Infection Control Limited
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 13 weeks, this is less cash available to meet short term requirements (128 weeks)
13 weeks - Aura Infection Control Limited
128 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 62.5%, this is a higher level of debt than the average (21.9%)
62.5% - Aura Infection Control Limited
21.9% - Industry AVG
AURA INFECTION CONTROL LIMITED financials
Aura Infection Control Limited's latest turnover from March 2024 is estimated at £3.9 million and the company has net assets of £662.1 thousand. According to their latest financial statements, Aura Infection Control Limited has 18 employees and maintains cash reserves of £271.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,989,016 | 1,707,192 | ||||||||
| Other Income Or Grants | 0 | 0 | ||||||||
| Cost Of Sales | 939,523 | 791,065 | ||||||||
| Gross Profit | 1,049,493 | 916,127 | ||||||||
| Admin Expenses | 940,029 | 708,561 | ||||||||
| Operating Profit | 109,464 | 207,566 | ||||||||
| Interest Payable | 15,101 | 34,966 | ||||||||
| Interest Receivable | 12 | 1 | ||||||||
| Pre-Tax Profit | 94,375 | 172,601 | ||||||||
| Tax | -45,354 | -33,175 | ||||||||
| Profit After Tax | 49,021 | 139,426 | ||||||||
| Dividends Paid | 120,000 | 0 | ||||||||
| Retained Profit | -70,979 | 139,426 | ||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 18 | 18 | 16 | 17 | 18 | 12 | 12 | 12 | 8 | |
| EBITDA* | 230,456 | 330,062 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 6,081 | 8,337 | 11,116 | 13,483 | 17,977 | 22,486 | 14,312 | 5,157 | 6,547 | 8,731 |
| Intangible Assets | 0 | 115,000 | 230,000 | 345,000 | 460,000 | 575,000 | 690,000 | 805,000 | 920,000 | 1,035,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 6,081 | 123,337 | 241,116 | 358,483 | 477,977 | 597,486 | 704,312 | 810,157 | 926,547 | 1,043,731 |
| Stock & work in progress | 131,629 | 208,101 | 219,453 | 310,816 | 199,601 | 148,926 | 84,705 | 87,925 | 48,464 | 101,050 |
| Trade Debtors | 606,476 | 342,868 | 498,095 | 403,070 | 526,996 | 328,203 | 333,009 | 271,270 | 146,903 | 232,781 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 747,875 | 504,658 | 318,782 | 318,666 | 32,344 | 180,756 | 165,736 | 153,198 | 125,169 | 0 |
| Cash | 271,711 | 205,858 | 175,019 | 119,990 | 5 | 11,936 | 8,367 | 7,691 | 1 | 20,408 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,757,691 | 1,261,485 | 1,211,349 | 1,152,542 | 758,946 | 669,821 | 591,817 | 520,084 | 320,537 | 354,239 |
| total assets | 1,763,772 | 1,384,822 | 1,452,465 | 1,511,025 | 1,236,923 | 1,267,307 | 1,296,129 | 1,330,241 | 1,247,084 | 1,397,970 |
| Bank overdraft | 644,813 | 451,082 | 521,403 | 322,274 | 167,281 | 204,150 | 256,212 | 254,431 | 174,912 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 159,705 | 167,088 | 123,509 | 82,853 | 217,787 | 50,074 | 92,929 | 77,315 | 112,068 | 1,330,879 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 1,213 | 2,746 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 220,895 | 146,975 | 125,413 | 148,002 | 272,895 | 251,455 | 172,217 | 189,535 | 32,620 | 0 |
| total current liabilities | 1,025,413 | 765,145 | 771,538 | 555,875 | 657,963 | 505,679 | 521,358 | 521,281 | 319,600 | 1,330,879 |
| loans | 74,784 | 180,239 | 310,861 | 497,325 | 5,833 | 15,833 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 1,255 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 326,597 | 427,608 | 597,563 | 669,641 | 848,626 | 0 |
| provisions | 1,520 | 1,584 | 2,112 | 2,562 | 3,416 | 4,272 | 2,719 | 980 | 1,309 | 0 |
| total long term liabilities | 76,304 | 181,823 | 312,973 | 501,142 | 335,846 | 447,713 | 600,282 | 670,621 | 849,935 | 0 |
| total liabilities | 1,101,717 | 946,968 | 1,084,511 | 1,057,017 | 993,809 | 953,392 | 1,121,640 | 1,191,902 | 1,169,535 | 1,330,879 |
| net assets | 662,055 | 437,854 | 367,954 | 454,008 | 243,114 | 313,915 | 174,489 | 138,339 | 77,549 | 67,091 |
| total shareholders funds | 662,055 | 437,854 | 367,954 | 454,008 | 243,114 | 313,915 | 174,489 | 138,339 | 77,549 | 67,091 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | 109,464 | 207,566 | ||||||||
| Depreciation | 2,859 | 2,779 | 3,706 | 4,494 | 5,992 | 7,496 | 4,770 | 1,722 | 2,184 | 2,917 |
| Amortisation | 115,000 | 115,000 | 115,000 | 115,000 | 115,000 | 115,000 | 115,000 | 115,000 | 115,000 | 115,000 |
| Tax | -45,354 | -33,175 | ||||||||
| Stock | -76,472 | -11,352 | -91,363 | 111,215 | 50,675 | 64,221 | -3,220 | 39,461 | -52,586 | 101,050 |
| Debtors | 506,825 | 30,649 | 95,141 | 162,396 | 50,381 | 10,214 | 74,277 | 152,396 | 39,291 | 232,781 |
| Creditors | -7,383 | 43,579 | 40,656 | -134,934 | 167,713 | -42,855 | 15,614 | -34,753 | -1,218,811 | 1,330,879 |
| Accruals and Deferred Income | 73,920 | 21,562 | -22,589 | -124,893 | 21,440 | 79,238 | -17,318 | 156,915 | 32,620 | 0 |
| Deferred Taxes & Provisions | -64 | -528 | -450 | -854 | -856 | 1,553 | 1,739 | -329 | 1,309 | 0 |
| Cash flow from operations | 272,343 | 260,388 | ||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -105,455 | -130,622 | -186,464 | 491,492 | -10,000 | 15,833 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | -1,213 | -2,788 | 4,001 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | -326,597 | -101,011 | -169,955 | -72,078 | -178,985 | 848,626 | 0 |
| share issue | ||||||||||
| interest | -15,089 | -34,965 | ||||||||
| cash flow from financing | -125,922 | -189,087 | ||||||||
| cash and cash equivalents | ||||||||||
| cash | 65,853 | 30,839 | 55,029 | 119,985 | -11,931 | 3,569 | 676 | 7,690 | -20,407 | 20,408 |
| overdraft | 193,731 | -70,321 | 199,129 | 154,993 | -36,869 | -52,062 | 1,781 | 79,519 | 174,912 | 0 |
| change in cash | -127,878 | 101,160 | -144,100 | -35,008 | 24,938 | 55,631 | -1,105 | -71,829 | -195,319 | 20,408 |
aura infection control limited Credit Report and Business Information
Aura Infection Control Limited Competitor Analysis
Perform a competitor analysis for aura infection control limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in L 1 area or any other competitors across 12 key performance metrics.
aura infection control limited Ownership
AURA INFECTION CONTROL LIMITED group structure
Aura Infection Control Limited has no subsidiary companies.
Ultimate parent company
AURA INFECTION CONTROL LIMITED
08814266
aura infection control limited directors
Aura Infection Control Limited currently has 1 director, Mrs Laura Edgar serving since Dec 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Laura Edgar | United Kingdom | 39 years | Dec 2013 | - | Director |
P&L
March 2024turnover
3.9m
+60%
operating profit
362.4k
0%
gross margin
38.5%
+2.64%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
662.1k
+0.51%
total assets
1.8m
+0.27%
cash
271.7k
+0.32%
net assets
Total assets minus all liabilities
aura infection control limited company details
company number
08814266
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
December 2013
age
12
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
hanover buildings, 11-13 hanover street, liverpool, merseyside, L1 3DN
Bank
-
Legal Advisor
-
aura infection control limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to aura infection control limited. Currently there are 1 open charges and 0 have been satisfied in the past.
aura infection control limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AURA INFECTION CONTROL LIMITED. This can take several minutes, an email will notify you when this has completed.
aura infection control limited Companies House Filings - See Documents
| date | description | view/download |
|---|
